clinical pharmacokinetic effects diet rich insoluble fiber parkinson disease pubmed ncbi abstract study effects diet rich insoluble fiber drif motor disability peripheral pharmacokinetics orally administered l-dopa parkinsonian patients marked constipation analyzed found effect drif plasma l-dopa concentration motor function greatest effect plasma l-dopa levels found early num num min oral administration relationship improvement constipation higher bioavailability l-dopa drif coadjuvant treatment patients parkinson's disease 
